Artificial Intelligence:
Improving Detection, Diagnosis, and Care of Prostate Cancer

Artificial intelligence is becoming an important tool in prostate cancer research, early detection, diagnosis, and treatment planning. While AI does not replace physicians, it can support them in several ways, including improving accuracy, reducing variability (differences in how doctors interpret the same scans or biopsies), and helping men receive more personalized care. This page highlights how AI is being used today and what researchers are studying for the future.

How AI Can Help Men Newly Diagnosed with Prostate Cancer

AA new diagnosis can feel overwhelming. Many men are unsure how serious their cancer is, whether tests were read correctly, and what to do next.

AI can help support doctors as they interpret MRIs, biopsies, and other test results. In some studies, AI tools have shown diagnostic performance similar to experienced specialists for certain tasks, while also improving consistency between readers (helping doctors agree more often when looking at the same findings).

For a newly diagnosed man, this may mean:

  • Fewer missed cancers on MRI
  • More consistent grading of biopsy samples (grading helps determine how aggressive the cancer is)
  • Better information to guide decisions about treatment or active surveillance (a monitoring plan for low-risk prostate cancer that avoids immediate treatment)

AI does not make the decision for you. It is one more tool that can help your medical team explain your cancer more clearly so you can make informed choices.

How AI Can Help Men Living with Prostate Cancer

PSA density (PSAD) adjusts the PSA number by factoring in prostate size. A larger prostate naturally produces more PSA, which can make the PSA level appear higher even without cancer. By dividing the PSA level by the volume of the prostate (measured on MRI or ultrasound), doctors can get a clearer picture of cancer risk. PSA density can help reduce unnecessary biopsies, but it is not a standalone test — it should be considered alongside PSA levels, imaging, and other clinical findings.

Prostate MRI (Multiparametric MRI, or mpMRI)

For men already living with prostate cancer, AI may help support ongoing care over time.

Researchers are exploring ways AI can:

  • Track changes seen on MRI (detailed prostate imaging) over years
  • Provide a second look at pathology slides (biopsy tissue reviewed under a microscope) to confirm findings
  • Help estimate which cancers are more likely to stay stable or progress (become more aggressive over time)
  • Support decisions about when to continue active surveillance and when to treat

Some AI tools are also being developed to help tailor follow-up schedules, treatment plans, and survivorship support. While these tools are still evolving, their goal is to make care more consistent and more personalized for each man.

AI in Early Detection and Screening

AI is being tested as a way to improve how prostate cancer is detected and evaluated, especially on imaging.

Examples include:

  • Analyzing prostate MRI to flag areas that could be cancer
  • Supporting PI-RADS scoring (the scoring system radiologists use to rate how suspicious an MRI finding is)
  • Helping radiologists focus on the most suspicious regions for targeted biopsy

In practice, AI is being developed to work alongside, not instead of, radiologists. It can act like a second set of eyes.

work alongside, not instead of, radiologists. It can act like a second set of eyes.

AI in MRI Interpretation

Multiparametric MRI (mpMRI, a detailed prostate MRI that uses several types of images) is an important tool for diagnosing and monitoring prostate cancer. AI models can assist radiologists by:

  • Segmenting the prostate and suspicious lesions (outlining the prostate and marking areas that look concerning)
  • Highlighting areas likely to be clinically significant cancer (cancer more likely to grow or spread)
  • Helping classify lesions into risk categories (grouping findings into low, medium, or higher risk)
  • Supporting decisions about whether a biopsy is needed

This may help reduce both underdiagnosis and overdiagnosis, especially in centers with less experience in prostate MRI.

AI in Digital Pathology

Multiparametric MRI (mpMRI, a detailed prostate MRI Pathologists diagnose prostate cancer by examining biopsy tissue under the microscope. AI has become a powerful aid in digital pathology (using computer-assisted tools to analyze biopsy slides).

AI pathology tools can:

  • Detect cancerous glands on digitized biopsy slides
  • Assist in assigning Gleason patterns and Grade Groups (how doctors grade how aggressive the cancer appears)
  • Help reduce variation between pathologists (differences in how specialists interpret the same slide)
  • Support faster, more efficient workflow (the steps pathologists follow to review biopsy samples)

Paige Prostate and Ibex Prostate Detect are examples of AI assisted tools designed to help pathologists detect prostate cancer on digital slides. These tools are intended to supplement, not replace, the judgment of trained pathologists, helping them catch more cancers and maintain consistent quality.

AI in Predicting Progression on Active Surveillance

For many men with low-risk prostate cancer, active surveillance (a structured monitoring plan that avoids treatment unless needed) is a recommended option. AI is being explored as a way to better predict which cancers are likely to stay indolent (slow-growing) and which might progress (begin to grow or become more aggressive).

Ongoing research includes:

  • Combining MRI findings, biopsy results, PSA trends, and clinical features into AI models
  • Using digital pathology images and AI to generate risk scores for progression
  • Supporting decisions about when to repeat imaging or biopsy

For men on active surveillance, this line of research aims to reduce unnecessary treatment while keeping care safe.

AI and Personalized Treatment Planning

For many men with low-risk prostate cancer, active AI is also being studied as a way to guide treatment choices and personalize therapy (tailoring treatment to the individual man).

Examples include:

  • Predicting which men will benefit from adding hormonal therapy to radiation
  • Estimating long-term outcomes such as recurrence risk (the chances of cancer coming back)
  • Helping design radiation therapy plans and contour target areas more efficiently (outlining the exact areas doctors need to treat)

The ArteraAI Prostate Test is an example of an AI based tool that analyzes digitized biopsy images to generate risk information and help predict which men with certain types of localized prostate cancer are more likely to benefit from adding hormone therapy to radiation. Tools like this are meant to support shared decision-making between men and their doctors.

AI for Patient Education and Support

AI is not only used behind the scenes. It can also help men and families manage day-to-day aspects of care.

AI powered tools and apps may:

  • Remind men about PSA tests, imaging, and follow-up visits
  • Help track symptoms, side effects, and quality of life
  • Offer general lifestyle guidance based on expert recommendations
  • Assist with clinical trial matching
  • Help navigate complex information about screening and guidelines

These tools do not replace medical advice, but they can help men stay organized, informed, and more engaged in their care.

Looking Ahead

AI in prostate cancer is an active and fast-moving area of research. There is strong interest in:

  • Improving early detection
  • Making diagnosis more accurate and consistent
  • Personalizing treatment plans
  • Reducing both overtreatment and undertreatment
  • Supporting long-term survivorship

Experts also emphasize the importance of safety, transparency, regulation, and reducing bias in AI tools (ensuring they work fairly for men of different ages, races, and backgrounds) before they are widely adopted.

AI is best viewed as a set of tools that can help doctors and patients make better decisions together. Men should always discuss test results and treatment options with their healthcare team and ask how new technologies, including AI, might or might not apply to their own situation.

Trusted Resources & Further Reading

*Disclaimer: The information on this page is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always talk with a qualified healthcare provider, such as a physician or urologist, about your personal situation, test results, and treatment options. Never delay seeking medical advice because of something you read online.